The current trajectory suggests 2024 will be far worse.
In the opening weeks of 2024, dengue fever has returned to Brazil not as a seasonal burden but as something closer to a reckoning — São Paulo's fourth death of the year arrives alongside case counts that have already doubled last January's toll, while the South of the country reports a nearly tenfold surge. Health authorities, armed with vaccines and projections, are now racing against a disease that has long been woven into the fabric of Brazilian summers, hoping that science and strategy can outpace a trajectory that points toward millions of infections before the year is done.
- São Paulo has recorded four dengue deaths and over 10,700 infections in less than a month — a pace twice as deadly as the same period last year.
- Southern Brazil is in freefall: Paraná, Santa Catarina, and Rio Grande do Sul together saw a 958% spike in cases in the first two weeks of January alone.
- National projections from Fiocruz warn of between 1.7 and 5 million cases in 2024, a figure that would shatter every previous record in Brazilian history.
- Children aged 10 to 14 are bearing the heaviest hospitalization burden, making them the priority target of an emergency vaccination rollout.
- The government has secured all 5.2 million available doses of the Qdenga vaccine for 2024, but experts quietly acknowledge the need may vastly exceed the supply.
On January 27th, São Paulo state confirmed its fourth dengue death of 2024, with victims spread across interior municipalities including Bebedouro, Jacareí, and Pindamonhangaba. The state has already logged more than 10,728 infections since New Year's Day — double the cases recorded in the same window of 2023. For context, all of last year brought 320,541 cases and 287 deaths across the state. The current trajectory suggests 2024 will be categorically worse.
The crisis extends well beyond São Paulo. Eight states and the Federal District have entered the year with case counts at least double those of early 2023. The situation is most alarming in the South, where Paraná, Santa Catarina, and Rio Grande do Sul together reported 10,961 cases in the first two weeks of January — a 958 percent increase over the 1,036 cases seen in the same period last year.
Federal health authorities, working alongside researchers at Fiocruz's InfoDengue group, have projected between 1.7 million and 5 million dengue cases nationally in 2024, with a central estimate of 3 million — figures that would dwarf any previous year on record.
In response, the Ministry of Health launched a vaccination campaign on January 20th, distributing 750,000 doses of the Qdenga vaccine through the public health system. Priority goes to high-transmission regions and to children and adolescents between 10 and 14, the age group most likely to require hospitalization. The government has secured all 5.2 million doses the manufacturer Takeda has available for 2024, with shipments arriving in stages through November. Whether that supply will be enough to slow a surge of potentially historic proportions remains deeply uncertain.
On Saturday, January 27th, health officials in São Paulo state announced the fourth death from dengue fever in 2024. The victim joined three others who had died in the interior municipalities of Bebedouro, Jacareí, and Pindamonhangaba. By that same date, the state had already recorded more than 10,728 confirmed infections since the new year began.
The pace is staggering. In the first month of 2024, São Paulo saw twice as many cases as it did during the same period in 2023, when 3,299 people were infected. To put the broader context in place: all of last year brought 320,541 cases and 287 deaths across the state. The current trajectory suggests 2024 will be far worse.
São Paulo is not alone. Eight states plus the Federal District have entered 2024 with case counts at least double what they were a year ago. But the crisis is most acute in the South. Paraná, Santa Catarina, and Rio Grande do Sul combined reported 10,961 dengue cases in the first two weeks of January—a 958 percent jump from the 1,036 cases recorded in the same window of 2023. The numbers are not trending upward. They are exploding.
National health authorities are bracing for what they expect will be a record year. The Ministry of Health, working with researchers at Fiocruz's InfoDengue group, issued projections in December forecasting between 1.7 million and 5 million dengue cases in Brazil in 2024, with a midpoint estimate of 3 million diagnoses. These figures dwarf any previous year on record.
In response, the government has begun a vaccination campaign. On January 20th, the Ministry of Health received 750,000 doses of the Qdenga vaccine to distribute through the public health system. The doses will be directed first to regions where dengue transmission is highest and to the age group bearing the heaviest hospitalization burden: children and adolescents between 10 and 14 years old. This initial shipment is part of a much larger commitment. The pharmaceutical company Takeda has provided 1.32 million doses at no cost to the Brazilian government, and the Ministry has purchased all 5.2 million doses the manufacturer has available for 2024. These will arrive in stages through November.
Vaccination strategy reflects the scale of the challenge. Doses will go to health regions in municipalities with populations of at least 100,000 people where dengue has circulated intensely over the past decade. The Ministry of Health developed these criteria in consultation with state and municipal health authorities. The logic is clear: vaccinate where the virus is most entrenched and where the young are most vulnerable. Whether 5.2 million doses will be enough to bend the curve remains an open question. The projections suggest the need will be far greater.
Citações Notáveis
All four confirmed deaths occurred in interior municipalities of São Paulo state— São Paulo State Health Department
Vaccination will prioritize high-transmission regions and children aged 10 to 14, who show the highest hospitalization rates— Brazilian Ministry of Health
A Conversa do Hearth Outra perspectiva sobre a história
Why is January 2024 so different from January 2023? Is this just seasonal variation?
No. The numbers are twice as high in São Paulo alone, and in the South they're nearly ten times higher. This isn't a normal fluctuation. Something about the conditions this year—weather, mosquito populations, viral circulation—has created a perfect storm.
And the deaths are concentrated in the interior, not the capital?
Yes. All four confirmed deaths so far are in smaller cities in the interior. That's worth watching. It might suggest the virus is spreading faster in areas with less robust health infrastructure.
The government is vaccinating children aged 10 to 14. Why that group specifically?
They're being hospitalized at the highest rates. Dengue can be mild, but it can also be severe—hemorrhagic dengue is dangerous. That age group is bearing the brunt right now, so that's where the vaccine is going first.
Five million doses sounds like a lot. Is it enough?
For a country of 215 million people facing projections of 3 million cases? It's a start. But the vaccine strategy is targeted, not universal. They're focusing on high-transmission zones and vulnerable ages. Whether that's enough depends on how fast the virus spreads in the next few months.
What happens if the projections are right and we hit 3 million cases?
The health system gets overwhelmed. Hospital beds fill. Some people don't get the care they need. The death toll rises. That's the scenario everyone is trying to prevent.